Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 12 entries
Sorted by: Best Match Show Resources per page
Evaluation of the DDSolver software applications.

BioMed research international

Zuo J, Gao Y, Bou-Chacra N, Löbenberg R.
PMID: 24877067
Biomed Res Int. 2014;2014:204925. doi: 10.1155/2014/204925. Epub 2014 Apr 27.

When a new oral dosage form is developed, its dissolution behavior must be quantitatively analyzed. Dissolution analysis involves a comparison of the dissolution profiles and the application of mathematical models to describe the drug release pattern. This report aims...

Cite
Zuo J, Gao Y, Bou-Chacra N, et al. Evaluation of the DDSolver software applications. Biomed Res Int. 2014;2014:204925doi: 10.1155/2014/204925.
Zuo, J., Gao, Y., Bou-Chacra, N., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed research international, 2014204925. https://doi.org/10.1155/2014/204925
Zuo, Jieyu, et al. "Evaluation of the DDSolver software applications." BioMed research international vol. 2014 (2014): 204925. doi: https://doi.org/10.1155/2014/204925
Zuo J, Gao Y, Bou-Chacra N, Löbenberg R. Evaluation of the DDSolver software applications. Biomed Res Int. 2014;2014:204925. doi: 10.1155/2014/204925. Epub 2014 Apr 27. PMID: 24877067; PMCID: PMC4022259.
Copy Download .nbib Format: NLM
Advances in dissolution instrumentation and their practical applications.

Drug development and industrial pharmacy

Culen M, Dohnal J.
PMID: 24093430
Drug Dev Ind Pharm. 2014 Oct;40(10):1277-82. doi: 10.3109/03639045.2013.841184. Epub 2013 Oct 04.

The rising demands on discriminatory and prediction abilities of dissolution methods and the increasing complexity of new drug products are the main driving forces of the progress in this field. The research moves forward as imperfections and shortcomings of...

Cite
Culen M, Dohnal J. Advances in dissolution instrumentation and their practical applications. Drug Dev Ind Pharm. 2013;40(10):1277-82doi: 10.3109/03639045.2013.841184.
Culen, M., & Dohnal, J. (2014). Advances in dissolution instrumentation and their practical applications. Drug development and industrial pharmacy, 40(10), 1277-82. https://doi.org/10.3109/03639045.2013.841184
Culen, Martin, and Dohnal, Jiri. "Advances in dissolution instrumentation and their practical applications." Drug development and industrial pharmacy vol. 40,10 (2014): 1277-82. doi: https://doi.org/10.3109/03639045.2013.841184
Culen M, Dohnal J. Advances in dissolution instrumentation and their practical applications. Drug Dev Ind Pharm. 2014 Oct;40(10):1277-82. doi: 10.3109/03639045.2013.841184. Epub 2013 Oct 04. PMID: 24093430.
Copy Download .nbib Format: NLM
Open innovation: Towards sharing of data, models and workflows.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Conrado DJ, Karlsson MO, Romero K, Sarr C, Wilkins JJ.
PMID: 28684136
Eur J Pharm Sci. 2017 Nov 15;109:S65-S71. doi: 10.1016/j.ejps.2017.06.035. Epub 2017 Jul 04.

Sharing of resources across organisations to support open innovation is an old idea, but which is being taken up by the scientific community at increasing speed, concerning public sharing in particular. The ability to address new questions or provide...

Cite
Conrado DJ, Karlsson MO, Romero K, et al. Open innovation: Towards sharing of data, models and workflows. Eur J Pharm Sci. 2017;109:S65-S71doi: 10.1016/j.ejps.2017.06.035.
Conrado, D. J., Karlsson, M. O., Romero, K., Sarr, C., & Wilkins, J. J. (2017). Open innovation: Towards sharing of data, models and workflows. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 109S65-S71. https://doi.org/10.1016/j.ejps.2017.06.035
Conrado, Daniela J, et al. "Open innovation: Towards sharing of data, models and workflows." European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences vol. 109 (2017): S65-S71. doi: https://doi.org/10.1016/j.ejps.2017.06.035
Conrado DJ, Karlsson MO, Romero K, Sarr C, Wilkins JJ. Open innovation: Towards sharing of data, models and workflows. Eur J Pharm Sci. 2017 Nov 15;109:S65-S71. doi: 10.1016/j.ejps.2017.06.035. Epub 2017 Jul 04. PMID: 28684136.
Copy Download .nbib Format: NLM
Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems.

Current drug delivery

Elmas A, Akyuz G, Bergal A, Andac M, Andac O.
PMID: 33438539
Curr Drug Deliv. 2021;18(8):1130-1136. doi: 10.2174/1567201818999210112181853.

BACKGROUND: pH sensitive dendrimers attached to nanocarriers, as one of the drug release systems, have become quite popular due to their ease of manufacture in experimental conditions and the ability to generate fast drug release in the targeted area....

Cite
Elmas A, Akyuz G, Bergal A, et al. Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Curr Drug Deliv. 2021;18(8):1130-1136doi: 10.2174/1567201818999210112181853.
Elmas, A., Akyuz, G., Bergal, A., Andac, M., & Andac, O. (2021). Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Current drug delivery, 18(8), 1130-1136. https://doi.org/10.2174/1567201818999210112181853
Elmas, Aykut, et al. "Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems." Current drug delivery vol. 18,8 (2021): 1130-1136. doi: https://doi.org/10.2174/1567201818999210112181853
Elmas A, Akyuz G, Bergal A, Andac M, Andac O. Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Curr Drug Deliv. 2021;18(8):1130-1136. doi: 10.2174/1567201818999210112181853. PMID: 33438539.
Copy Download .nbib Format: NLM
Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems.

Current drug delivery

Elmas A, Akyuz G, Bergal A, Andac M, Andac O.
PMID: 33438539
Curr Drug Deliv. 2021;18(8):1130-1136. doi: 10.2174/1567201818999210112181853.

BACKGROUND: pH sensitive dendrimers attached to nanocarriers, as one of the drug release systems, have become quite popular due to their ease of manufacture in experimental conditions and the ability to generate fast drug release in the targeted area....

Cite
Elmas A, Akyuz G, Bergal A, et al. Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Curr Drug Deliv. 2021;18(8):1130-1136doi: 10.2174/1567201818999210112181853.
Elmas, A., Akyuz, G., Bergal, A., Andac, M., & Andac, O. (2021). Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Current drug delivery, 18(8), 1130-1136. https://doi.org/10.2174/1567201818999210112181853
Elmas, Aykut, et al. "Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems." Current drug delivery vol. 18,8 (2021): 1130-1136. doi: https://doi.org/10.2174/1567201818999210112181853
Elmas A, Akyuz G, Bergal A, Andac M, Andac O. Enhanced Analytic Approach for Describing pH Triggered Fast Drug Release Systems. Curr Drug Deliv. 2021;18(8):1130-1136. doi: 10.2174/1567201818999210112181853. PMID: 33438539.
Copy Download .nbib Format: NLM
Advancement in nanogel formulations provides controlled drug release.

International journal of pharmaceutics

Ahmed S, Alhareth K, Mignet N.
PMID: 32439585
Int J Pharm. 2020 Jun 30;584:119435. doi: 10.1016/j.ijpharm.2020.119435. Epub 2020 May 19.

Nanogels are currently considered as promising nanosized drug delivery carriers. Nanogels are made of a crosslinked polymeric network which could encapsulate both hydrophilic and hydrophobic drugs due to their tunable nature. The ability of nanogels to control drug release...

Cite
Ahmed S, Alhareth K, Mignet N. Advancement in nanogel formulations provides controlled drug release. Int J Pharm. 2020;584:119435doi: 10.1016/j.ijpharm.2020.119435.
Ahmed, S., Alhareth, K., & Mignet, N. (2020). Advancement in nanogel formulations provides controlled drug release. International journal of pharmaceutics, 584119435. https://doi.org/10.1016/j.ijpharm.2020.119435
Ahmed, Shayan, et al. "Advancement in nanogel formulations provides controlled drug release." International journal of pharmaceutics vol. 584 (2020): 119435. doi: https://doi.org/10.1016/j.ijpharm.2020.119435
Ahmed S, Alhareth K, Mignet N. Advancement in nanogel formulations provides controlled drug release. Int J Pharm. 2020 Jun 30;584:119435. doi: 10.1016/j.ijpharm.2020.119435. Epub 2020 May 19. PMID: 32439585.
Copy Download .nbib Format: NLM
Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods.

The AAPS journal

Gomeni R, Bressolle-Gomeni F.
PMID: 32297044
AAPS J. 2020 Apr 15;22(3):67. doi: 10.1208/s12248-020-00445-0.

Different approaches based on deconvolution and convolution analyses have been proposed to establish IVIVC. A new implementation of the convolution-based model was used to evaluate the time-scaled IVIVC using the convolution (method 1) and the deconvolution-based (method 2) approaches....

Cite
Gomeni R, Bressolle-Gomeni F. Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods. AAPS J. 2020;22(3):67doi: 10.1208/s12248-020-00445-0.
Gomeni, R., & Bressolle-Gomeni, F. (2020). Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods. The AAPS journal, 22(3), 67. https://doi.org/10.1208/s12248-020-00445-0
Gomeni, Roberto, and Bressolle-Gomeni, Françoise. "Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods." The AAPS journal vol. 22,3 (2020): 67. doi: https://doi.org/10.1208/s12248-020-00445-0
Gomeni R, Bressolle-Gomeni F. Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods. AAPS J. 2020 Apr 15;22(3):67. doi: 10.1208/s12248-020-00445-0. PMID: 32297044.
Copy Download .nbib Format: NLM
Drug delivery systems for programmed and on-demand release.

Advanced drug delivery reviews

Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH.
PMID: 30415656
Adv Drug Deliv Rev. 2018 Jul;132:104-138. doi: 10.1016/j.addr.2018.07.002. Epub 2018 Jul 06.

With the advancement in medical science and understanding the importance of biodistribution and pharmacokinetics of therapeutic agents, modern drug delivery research strives to utilize novel materials and fabrication technologies for the preparation of robust drug delivery systems to combat...

Cite
Davoodi P, Lee LY, Xu Q, et al. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018;132:104-138doi: 10.1016/j.addr.2018.07.002.
Davoodi, P., Lee, L. Y., Xu, Q., Sunil, V., Sun, Y., Soh, S., & Wang, C. H. (2018). Drug delivery systems for programmed and on-demand release. Advanced drug delivery reviews, 132104-138. https://doi.org/10.1016/j.addr.2018.07.002
Davoodi, Pooya, et al. "Drug delivery systems for programmed and on-demand release." Advanced drug delivery reviews vol. 132 (2018): 104-138. doi: https://doi.org/10.1016/j.addr.2018.07.002
Davoodi P, Lee LY, Xu Q, Sunil V, Sun Y, Soh S, Wang CH. Drug delivery systems for programmed and on-demand release. Adv Drug Deliv Rev. 2018 Jul;132:104-138. doi: 10.1016/j.addr.2018.07.002. Epub 2018 Jul 06. PMID: 30415656.
Copy Download .nbib Format: NLM
Automated digital design for 3D-printed individualized therapies.

International journal of pharmaceutics

Eleftheriadis GK, Kantarelis E, Monou PK, Andriotis EG, Bouropoulos N, Tzimtzimis EK, Tzetzis D, Rantanen J, Fatouros DG.
PMID: 33662466
Int J Pharm. 2021 Apr 15;599:120437. doi: 10.1016/j.ijpharm.2021.120437. Epub 2021 Mar 01.

Customization of pharmaceutical products is a central requirement for personalized medicines. However, the existing processing and supply chain solutions do not support such manufacturing-on-demand approaches. In order to solve this challenge, three-dimensional (3D) printing has been applied for customization...

Cite
Eleftheriadis GK, Kantarelis E, Monou PK, et al. Automated digital design for 3D-printed individualized therapies. Int J Pharm. 2021;599:120437doi: 10.1016/j.ijpharm.2021.120437.
Eleftheriadis, G. K., Kantarelis, E., Monou, P. K., Andriotis, E. G., Bouropoulos, N., Tzimtzimis, E. K., Tzetzis, D., Rantanen, J., & Fatouros, D. G. (2021). Automated digital design for 3D-printed individualized therapies. International journal of pharmaceutics, 599120437. https://doi.org/10.1016/j.ijpharm.2021.120437
Eleftheriadis, Georgios K, et al. "Automated digital design for 3D-printed individualized therapies." International journal of pharmaceutics vol. 599 (2021): 120437. doi: https://doi.org/10.1016/j.ijpharm.2021.120437
Eleftheriadis GK, Kantarelis E, Monou PK, Andriotis EG, Bouropoulos N, Tzimtzimis EK, Tzetzis D, Rantanen J, Fatouros DG. Automated digital design for 3D-printed individualized therapies. Int J Pharm. 2021 Apr 15;599:120437. doi: 10.1016/j.ijpharm.2021.120437. Epub 2021 Mar 01. PMID: 33662466.
Copy Download .nbib Format: NLM
Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers.

The Tokai journal of experimental and clinical medicine

Tajiri S, Kondo T, Tanigaki T, Asano K, Hibino M, Horiuchi S, Kobayashi I, Nishiya K.
PMID: 32901895
Tokai J Exp Clin Med. 2020 Sep 20;45(3):102-107.

OBJECTIVE: Dry powder inhalers (DPIs) are classified as capsule, blister, and reservoir types. Currently, two reservoir-type DPIs, i.e., TurbuhalerMETHODS: An inhalation f low simulator was set to reach peak inhalation f low (PIF) at two time points, 0.4 s...

Cite
Tajiri S, Kondo T, Tanigaki T, et al. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers. Tokai J Exp Clin Med. 2020;45(3):102-107
Tajiri, S., Kondo, T., Tanigaki, T., Asano, K., Hibino, M., Horiuchi, S., Kobayashi, I., & Nishiya, K. (2020). Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers. The Tokai journal of experimental and clinical medicine, 45(3), 102-107.
Tajiri, Sakurako, et al. "Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers." The Tokai journal of experimental and clinical medicine vol. 45,3 (2020): 102-107.
Tajiri S, Kondo T, Tanigaki T, Asano K, Hibino M, Horiuchi S, Kobayashi I, Nishiya K. Analysis of Drug Release Dynamics of the Reservoir-type Dry Powder Inhalers. Tokai J Exp Clin Med. 2020 Sep 20;45(3):102-107. PMID: 32901895.
Copy Download .nbib Format: NLM
Catalogue of self-targeting nano-medical inventions to accelerate clinical trials.

Biomaterials science

Alsudir SA, Almalik A, Alhasan AH.
PMID: 33912874
Biomater Sci. 2021 Jun 04;9(11):3898-3910. doi: 10.1039/d1bm00235j.

Repetitive outbreaks and prolonged epidemics represent mortal threats to global health, creating chaos in our globalized world. To date, scientists have been compelled to follow FDA guidelines for conventional clinical trials, which decelerates the release of effective therapies to...

Cite
Alsudir SA, Almalik A, Alhasan AH. Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. Biomater Sci. 2021;9(11):3898-3910doi: 10.1039/d1bm00235j.
Alsudir, S. A., Almalik, A., & Alhasan, A. H. (2021). Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. Biomaterials science, 9(11), 3898-3910. https://doi.org/10.1039/d1bm00235j
Alsudir, Samar A, et al. "Catalogue of self-targeting nano-medical inventions to accelerate clinical trials." Biomaterials science vol. 9,11 (2021): 3898-3910. doi: https://doi.org/10.1039/d1bm00235j
Alsudir SA, Almalik A, Alhasan AH. Catalogue of self-targeting nano-medical inventions to accelerate clinical trials. Biomater Sci. 2021 Jun 04;9(11):3898-3910. doi: 10.1039/d1bm00235j. PMID: 33912874.
Copy Download .nbib Format: NLM
Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform.

Chemical communications (Cambridge, England)

Cheng CA, Chen W, Zhang L, Wu HH, Zink JI.
PMID: 32756711
Chem Commun (Camb). 2020 Sep 14;56(71):10297-10300. doi: 10.1039/d0cc03179h. Epub 2020 Aug 05.

We developed a theranostic approach exemplifying a concept called an "exchange method" that controls and "images" drug release from nanoparticles using magnetic resonance imaging-guided high-intensity focused ultrasound. The controllable amount of released drug and therapeutic efficacy can be self-reported...

Cite
Cheng CA, Chen W, Zhang L, et al. Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform. Chem Commun (Camb). 2020;56(71):10297-10300doi: 10.1039/d0cc03179h.
Cheng, C. A., Chen, W., Zhang, L., Wu, H. H., & Zink, J. I. (2020). Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform. Chemical communications (Cambridge, England), 56(71), 10297-10300. https://doi.org/10.1039/d0cc03179h
Cheng, Chi-An, et al. "Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform." Chemical communications (Cambridge, England) vol. 56,71 (2020): 10297-10300. doi: https://doi.org/10.1039/d0cc03179h
Cheng CA, Chen W, Zhang L, Wu HH, Zink JI. Magnetic resonance imaging of high-intensity focused ultrasound-stimulated drug release from a self-reporting core@shell nanoparticle platform. Chem Commun (Camb). 2020 Sep 14;56(71):10297-10300. doi: 10.1039/d0cc03179h. Epub 2020 Aug 05. PMID: 32756711.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 12 entries